NASDAQ:INBX | Cash Flow Statement | Inhibrx Biosciences, Inc.

Complete source-backed cash-flow history.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$36.65M$523,000.00
2026-03-31-$33.44M$537,000.00-$38.03M$0.00$0.00$75.46M
2025-12-31-$32.83M$564,000.00-$30.12M$0.00$0.00$1.25M
2025-09-30-$35.26M$582,000.00
2025-06-30-$28.65M$662,000.00
2025-03-31-$43.31M$675,000.00-$35.9M$21,000.00-$21,000.00$99.84M
2024-12-31-$47.87M$689,000.00-$43.72M$16,000.00-$16,000.00$0.00
2024-09-30-$43.86M$760,000.00
2024-06-30$1.86B$475,000.00
2024-03-31-$78.71M$360,000.00-$63.05M$1.12M-$1.12M$38.73M
2023-12-31-$93.6M$298,000.00-$56.82M$3.44M-$3.44M$860,000.00
2023-09-30-$51.79M$304,000.00
2023-06-30-$47.05M$295,000.00
2023-03-31-$48.92M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$140.06M$2.48M-$129.79M$31,000.00-$28,000.00$101.45M
2024-12-31$1.69B$2.29M-$194.41M$2.6M-$2.6M$71.68M
2023-12-31-$241.36M$1.19M-$193.31M$4.59M-$4.59M$201.96M